2036 related articles for article (PubMed ID: 33119871)
41. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.
Kuo CL; Chou HY; Chiu YC; Cheng AN; Fan CC; Chang YN; Chen CH; Jiang SS; Chen NJ; Lee AY
Cancer Lett; 2020 Apr; 474():138-150. PubMed ID: 31987921
[TBL] [Abstract][Full Text] [Related]
42. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
43. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
Angrini M; Varthaman A; Cremer I
Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
[TBL] [Abstract][Full Text] [Related]
44. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
Laha D; Grant R; Mishra P; Nilubol N
Front Immunol; 2021; 12():656908. PubMed ID: 33986746
[TBL] [Abstract][Full Text] [Related]
45. Crosstalk among m
Zhang F; Liu H; Duan M; Wang G; Zhang Z; Wang Y; Qian Y; Yang Z; Jiang X
J Hematol Oncol; 2022 Jul; 15(1):84. PubMed ID: 35794625
[TBL] [Abstract][Full Text] [Related]
46. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.
van der Heide CD; Dalm SU
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4616-4641. PubMed ID: 35788730
[TBL] [Abstract][Full Text] [Related]
47. New insights into the role of EMT in tumor immune escape.
Terry S; Savagner P; Ortiz-Cuaran S; Mahjoubi L; Saintigny P; Thiery JP; Chouaib S
Mol Oncol; 2017 Jul; 11(7):824-846. PubMed ID: 28614624
[TBL] [Abstract][Full Text] [Related]
48. The Janus Face of Tumor Microenvironment Targeted by Immunotherapy.
Buoncervello M; Gabriele L; Toschi E
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484464
[TBL] [Abstract][Full Text] [Related]
49. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
50. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape.
Osipov A; Saung MT; Zheng L; Murphy AG
J Immunother Cancer; 2019 Aug; 7(1):224. PubMed ID: 31439034
[TBL] [Abstract][Full Text] [Related]
51. Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation.
Guo S; Deng CX
Int J Biol Sci; 2018; 14(14):2083-2093. PubMed ID: 30585271
[TBL] [Abstract][Full Text] [Related]
52. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
[TBL] [Abstract][Full Text] [Related]
53. Steps in metastasis: an updated review.
Majidpoor J; Mortezaee K
Med Oncol; 2021 Jan; 38(1):3. PubMed ID: 33394200
[TBL] [Abstract][Full Text] [Related]
54. Crosstalk Between Mesenchymal Stromal Cells and Tumor-Associated Macrophages in Gastric Cancer.
Zheng P; Li W
Front Oncol; 2020; 10():571516. PubMed ID: 33163402
[TBL] [Abstract][Full Text] [Related]
55. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
[TBL] [Abstract][Full Text] [Related]
56. The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities.
Neophytou CM; Panagi M; Stylianopoulos T; Papageorgis P
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922795
[TBL] [Abstract][Full Text] [Related]
57. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
Razmkhah M; Abtahi S; Ghaderi A
Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
[TBL] [Abstract][Full Text] [Related]
58. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
59. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
[TBL] [Abstract][Full Text] [Related]
60. Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Zhao Y; Shen M; Wu L; Yang H; Yao Y; Yang Q; Du J; Liu L; Li Y; Bai Y
Cell Death Dis; 2023 Sep; 14(9):587. PubMed ID: 37666813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]